生命科学资讯

Genmab halts enrollment for cancer drug from ProfoundBio buyout

Canaccord Genuity raises Illumina stock price target to $150 on solid results - Investing.com

From detection to prevention: How sponsored testing can transform patient outcomes

The crucial role of raw material selection for success in cell therapy manufacturing

Lonza Group AG (LONN.SW, SIX): CHF550.20 intraday ahead of 28 Jan earnings — what to watch - Meyka

AEGON ASSET MANAGEMENT UK Plc Purchases 13,857 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat

'Things are looking up': British biotechs consider going public after yearslong IPO drought

A Look At 10x Genomics (TXG) Valuation After New Collaborations And Revenue Above Guidance - simplywall.st

Whittier Trust Co. Purchases 26,584 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat

Wealth Enhancement Advisory Services LLC Buys 9,997 Shares of Illumina, Inc. $ILMN - MarketBeat

Waters Corporation $WAT Shares Acquired by Quilter Plc - MarketBeat

PIKFYVE inhibition mitigates disease in models of diverse forms of ALS

Agilent Technologies, Inc. $A Shares Sold by Teacher Retirement System of Texas - MarketBeat

iA Global Asset Management Inc. Purchases New Position in Illumina, Inc. $ILMN - MarketBeat

CIBC Asset Management Inc Trims Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat

Assessing Agilent Technologies (A) Valuation After New AI Slide Scanner Launch In Europe - Yahoo Finance

Can H5N1 avian influenza in dairy cattle be contained in the US?

Is It Time To Reconsider Illumina (ILMN) After Mixed Multi Year Share Performance? - Yahoo Finance

Will Agilent’s AI-Enabled Digital Pathology Push Reshape Agilent Technologies' (A) Diagnostics Narrative? - Yahoo Finance New Zealand

Will Agilent’s AI-Enabled Digital Pathology Push Reshape Agilent Technologies' (A) Diagnostics Narrative? - Yahoo Finance